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See related research by Karagiannidis et al. http://ccforum.com/content/18/3/R124We read with interest the article by Karagiannidis and
colleagues reporting the effects of extracorporeal CO2
removal (ECCO2R) in a pig model of severe respiratory
acidosis [1]. However, their conclusion that blood flow
rates between 750 and 1,000 ml/minute are necessary to
correct severe acidosis using ECCO2R may have been
biased by limitations in experimental methodology.
Firstly, the authors report CO2 removal rates for vari-
ous blood flow rates using 19Fr and 14Fr catheters.
However, the data clearly demonstrated blood recircula-
tion using the 14Fr catheter, reducing CO2 removal effi-
ciency. Although the authors mention this limitation, it
is curious why the 14Fr data were presented at all, since
recirculation confounds meaningful interpretation.
Secondly, a 15-minute equilibration time was used be-
tween experimental set points, but no evidence is pro-
vided that equilibrium was achieved. It is reasonable to* Correspondence: mdcmec@nus.edu.sg
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article, unless otherwise stated.expect equilibration within 15 minutes when the entire
cardiac output participates in gas exchange, but in this
study blood flow rates of only 200 to 1,000 ml/minute
passed through the gas exchanger. Longer equilibration
times may have resulted in continued pH correction, as
demonstrated in a human ECCO2R pilot study using ap-
proximately 450 ml/minute blood flows [2].
Finally, this study demonstrates reductions of partial pres-
sure of CO2 from 107.9 to 76.9 mmHg with blood flows of
500 ml/minute. In clinical practice this may be sufficient, a
reduction from 80-85 to 60-65 mmHg in chronic obstruct-
ive pulmonary disease patients with respiratory acidosis
normalized pH, allowing intubation to be avoided [2].
Although ECCO2R with higher blood flows clearly in-
creases CO2 removal, lower flows with appropriately de-
signed catheters may provide sufficient support for
severe hypercapnic respiratory failure.We are grateful for the comments to our recent manu-
script [1] provided by Cove and Federspiel and we very
much appreciate their effort in further elucidating the
concept of ECCO2R. We are happy to respond to their
comments as follows.
Cove and Federspiel are correct in stating that ECCO2R
was insufficient using 14.5Fr catheters and that this was
also attributable to recirculation. It was one of the inten-
tions of our study to explicitly show this [1]. However,
ECCO2R was insufficient in our experimental setting, too,
when using 19Fr catheters at blood flow rates of 500 ml/
minute while recirculation was negligible. This indicatesthat lower blood rates per se contributed to insufficient
ECCO2R.
We agree that equilibrium for CO2 may not have been
completed after 15 minutes, because bicarbonate is
stored in slow compartments. However, in addition to
the information already given in the methods section we
observed that CO2 measures at the exhaust outlet were
very stable after 15 minutes, supporting the assumption
that equilibrium for CO2 was largely achieved.
Finally, we acknowledge the existing, albeit small sci-
entific evidence for the clinical application of ECCO2R
in patients. The patients in the study mentioned were
far less acidotic, were mostly breathing spontaneously
and were in a fairly stable condition [2]. Therefore, the
results of our study setting with severely acidotic pigs
are not transferrable to these conditions. To normalize
severe respiratory acidosis, blood flows in the range ofCentral. This is an Open Access article distributed under the terms of the
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cient to avoid intubation in non-invasive ventilation fail-
ure under certain conditions.
Abbreviation
ECCO2R: Extracorporeal CO2 removal.
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